Selected Drugs Clear All
MultiCheck Results
- 9
Interactions
Avoid/Use Alternative |
||
|
doxylamine
(generic) + Rexulti
(brexpiprazole) |
||
Avoid/Use Alternativedoxylamine + brexpiprazole avoid combo if doxylamine use for pregnancy-related nausea/vomiting, otherwise caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects) |
||
|
doxylamine
(generic) + Zyprexa
(olanzapine) |
||
Avoid/Use Alternativedoxylamine + olanzapine avoid combo if doxylamine use for pregnancy-related nausea/vomiting; otherwise, consider alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis), life-threatening anticholinergic adverse effects, including constipation, paralytic ileus, hyperthermia (additive effects) |
||
|
Rexulti
(brexpiprazole) + Zyprexa
(olanzapine) |
||
Avoid/Use Alternativebrexpiprazole + olanzapine use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy) |
||
Monitor/Modify Tx |
||
|
Kenalog-40
(triamcinolone acetonide) + nabumetone
(generic) |
||
Monitor/Modify Txtriamcinolone + nabumetone monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding, including life-threatening (additive effects) |
||
|
Kenalog-40
(triamcinolone acetonide) + Zepbound
(tirzepatide) |
||
Monitor/Modify Txtriamcinolone + tirzepatide monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects) |
||
|
Rexulti
(brexpiprazole) + Zepbound
(tirzepatide) |
||
Monitor/Modify Txbrexpiprazole + tirzepatide monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects) |
||
|
Zepbound
(tirzepatide) + Zyprexa
(olanzapine) |
||
Monitor/Modify Txtirzepatide + olanzapine monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects) |
||
Caution Advised |
||
|
Claravis
(isotretinoin) + Kenalog-40
(triamcinolone acetonide) |
||
Caution Advisedisotretinoin + triamcinolone caution advised: combo may incr. risk of bone loss (additive effects) |
||
|
Kenalog-40
(triamcinolone acetonide) + Pulmicort Respules
(budesonide inhaled) |
||
Caution Advisedtriamcinolone + budesonide inhaled caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy) |
||
Additional Considerations |
||
|
tirzepatide
in Zepbound
|
||
|
caution advised with oral drugs, especially narrow therapeutic index; tirzepatide delays gastric emptying, may alter absorption of concomitant oral drugs |
||